XLV Holdings Information

XLV is an equity ETF with a total of 63 individual holdings. The top holdings are Eli Lilly and Company stock at 15.71%, Johnson & Johnson at 10.38%, AbbVie at 7.29%, UnitedHealth Group at 5.96%, and Merck & Co. at 5.51%.

Total Holdings

Top 10 Percentage

60.72%

Asset Class

Equity

ETF Category

Health

Assets

45.21B

PE Ratio

25.07

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	15.71%	5,724,487
2	JNJ	Johnson & Johnson	10.38%	17,419,661
3	ABBV	AbbVie Inc.	7.29%	12,785,348
4	UNH	UnitedHealth Group Incorporated	5.96%	6,571,726
5	MRK	Merck & Co., Inc.	5.51%	17,872,725
6	AMGN	Amgen Inc.	3.71%	3,905,565
7	TMO	Thermo Fisher Scientific Inc.	3.64%	2,689,230
8	ABT	Abbott Laboratories	3.19%	12,604,466
9	GILD	Gilead Sciences, Inc.	2.82%	8,984,595
10	PFE	Pfizer Inc.	2.51%	41,243,592
11	ISRG	Intuitive Surgical, Inc.	2.34%	2,562,824
12	BMY	Bristol-Myers Squibb Company	2.17%	14,777,305
13	VRTX	Vertex Pharmaceuticals Incorporated	2.16%	1,836,643
14	DHR	Danaher Corporation	2.11%	4,558,362
15	CVS	CVS Health Corporation	1.99%	9,233,089
16	SYK	Stryker Corporation	1.94%	2,496,775
17	MDT	Medtronic plc	1.91%	9,290,657
18	MCK	McKesson Corporation	1.69%	869,858
19	ELV	Elevance Health, Inc.	1.42%	1,571,435
20	REGN	Regeneron Pharmaceuticals, Inc.	1.32%	723,098
21	BSX	Boston Scientific Corporation	1.26%	10,755,884
22	CI	The Cigna Group	1.21%	1,914,276
23	HCA	HCA Healthcare, Inc.	1.05%	1,123,690
24	COR	Cencora, Inc.	0.99%	1,407,937
25	CAH	Cardinal Health, Inc.	0.89%	1,694,849

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of Aug 13, 2026